Genomics

Dataset Information

Ezetimibe derivative L14-8 suppresses advanced prostate cancer by activating PLK1/TP53-SAT1-induced ferroptosis


ABSTRACT: Ezetimibe derivative L14-8 suppresses advanced prostate cancer by activating PLK1/TP53-SAT1-induced ferroptosis

PROVIDER: PRJNA1159398 | ENA |

REPOSITORIES: ENA